

EMJ GOLD: Pharma news, views and analysis
EMJ
Join the EMJ GOLD team for a weekly exploration of all things pharma, featuring thought-provoking conversations, insightful interviews with high-profile industry guests and discussions about the latest trends and innovations taking the pharmaceutical sphere by storm.
Whether its marketing, medical affairs, the use of digital techniques to create patient-centric approaches or something in between, there's something here for anyone interested in the pharmaceutical industry.
Whether its marketing, medical affairs, the use of digital techniques to create patient-centric approaches or something in between, there's something here for anyone interested in the pharmaceutical industry.
Episodes
Mentioned books

Nov 16, 2021 • 21min
Dr Richard Kaszynski on the Importance of Antivirals
We talk to Dr Richard Kaszynski, Chief Medical Officer, AiPharma, who discusses the emerging role of antivirals in healthcare. He explores his work on the GUARDIAN program, the benefits of drug repurposing, the importance of keeping patients out of hospitals and his highlights from the past year.

Nov 9, 2021 • 20min
Tanja Dowe on Investing in Digital Health Tools
This week, Tanja Dowe, CEO, Debiopharm Innovation Fund, discusses her passion for digital health tools. Drawing on her experience of investing in health technologies, she explores what it takes to be a successful entrepreneur, how these tools could improve life expectancies in cancer, and her highlights from a year of digital transformation for the pharmaceutical industry.

Nov 2, 2021 • 6min
Pharma's Month in Review
This week, we take a look back at the standout moments in the pharmaceutical industry from October, covering the latest in COVID-19 developments, the most notable mergers and acquisitions, marketing highlights, and the latest in research and development.

Oct 26, 2021 • 28min
Dr Emma Roffe and Eric Low on Combination Treatments
We talk to Dr Emma Roffe, Oncology Country Head, Takeda UK, and Eric Low, Founder, Myeloma UK, about the challenge of combination treatments. The two discuss a pair of whitepapers recently produced by Takeda, which uncover why challenges exist, why for so long it has been classified as 'too hard to solve', as well as potential solutions that could revolutionise this area of healthcare. Disclaimer: This episode is editorially owned by EMG GOLD.

Oct 19, 2021 • 18min
Massimiliano Siciliano on The Potential of Digital
We talk to Massimiliano Siciliano, Digital Solution Director Europe, Novartis, about the potential of digital solutions for the pharmaceutical industry's stakeholders and commercial teams, the technology he is most excited about within pharma's digital revolution, and his three key principles for building high performing teams.

Oct 12, 2021 • 24min
Clare Hague on Drug Pricing and Market Access
We talk to Clare Hague, Senior Director, Haematology Market Access, Europe, the Middle East, and Africa, Janssen. She shares her perspective on the industry's drug pricing challenges and opportunities, details alternative pricing systems that could improve access in low-to-middle-income countries, and explores the shifting market access landscape within oncology.

Oct 5, 2021 • 7min
Pharma's Month in Review
This week, we look back at the highlights in pharma throughout September, covering the latest in COVID-19 developments, the most notable mergers and acquisitions, marketing standouts, and the latest in research and development news.

Sep 28, 2021 • 17min
Matt Atkinson and Megan Reutin on Reuters Events Pharma 2021
We talk to Matt Atkinson, Global Projects Director, Reuters Events Pharma, and Megan Reutin, Global Head of Omnichannel Analytics, Grünenthal Group, about the upcoming Reuters Pharma 2021 Event. We get a sneak peek into the event's line-up, consider the future of virtual events, and explore the rapid digital transformation that has taken place over the past year.

Sep 21, 2021 • 17min
Julie Ross on International Equal Pay Day
We talk to Julie Ross, President, Advanced Clinical, about gender parity in the workplace in aid of International Equal Pay Day. In the discussion, she covers her journey to leadership, the importance of determination and resilience, and why gender parity in healthcare and life sciences is so essential.

Sep 14, 2021 • 21min
Carol Lynch on Corporate Responsibility
We talk to Carol Lynch, Chief Business Officer, Sandoz, about how to increase the number of women in leadership positions in the pharmaceutical industry, the importance of mental health provisions in the workplace, and Sandoz's role in increasing access to biosimilars around the world.


